Navigation Links
Biodel Obtains Exclusive License to Aegis Therapeutics' Technologies for Development and Commercialization of Glucagon Pharmaceutical Formulations
Date:6/8/2012

gnificantly strengthening our pipeline."

Aegis Therapeutics' chief executive officer Dr. Edward T. Maggio stated: "We are pleased to be working with Biodel on this exciting application of our technology and look forward to a fruitful relationship as Biodel works toward commercializing a number of different glucagon products utilizing our patented or propriety ProTek® and Intravail® technologies."

Glucagon is a peptide hormone that stimulates the breakdown of the liver's glycogen stores into glucose, thereby raising blood glucose levels.  Glucagon is prescribed to patients with diabetes for use by a caregiver in case of incapacitating severe hypoglycemia.  The need for a convenient, ready-to-use formulation is heightened by the increasing usage of intensive insulin therapy, which can increase the incidence of severe hypoglycemia. 

Due to the inherent instability of glucagon, currently available rescue products are lyophilized, two-part presentations that require a caregiver to perform multiple manipulations to reconstitute the drug into a solution prior to injection.  This process is difficult for many caregivers to perform during an emergency situation when the patient is semi-conscious, unconscious, or having a seizure from hypoglycemia.  The complexity of the reconstitution and injection process results in a requirement for the potential caregivers to schedule and undergo training in a physician's office.  The combination of this training requirement and the difficulty many caregivers have with the process limits the number of patients who choose to keep a glucagon rescue product on hand at home, office or school.

Utilizing Aegis' technology, Biodel is developing formulations of glucagon designed to be more stable in solution at both refrigerated and room temperatures than existing commercial formulations.  Accelerated stability data indicates that ProTek®-based glucagon formulat
'/>"/>

SOURCE Biodel Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Biodels Intellectual Property Position Strengthened for Ultra-Rapid-Acting Insulin Programs by Notice of Intent to Grant from European Patent Office
2. Biodel to Report Second Quarter Fiscal Year 2012 Financial Results on May 10, 2012
3. Islet Sciences Announces Exclusive License Agreement with Yale University to Commercialize an Early Beta Cell Destruction and Diabetes Diagnostic
4. Exclusive Industry Panel for Medical Device Developers - "The Great Innovators: A Sit-Down Chat with Dr. Thomas Fogarty & Dean Kamen"
5. SurgLine International, Inc. Chief Executive Officer, Thomas Toland, Exclusive Interview on Stock Traders Talk Radio
6. Debiopharm and Vifor Pharma Sign an Exclusive Agreement for the Distribution and Commercialization of Pamorelin®LA in Switzerland - A Drug Treatment for Prostate Cancer and Endometriosis
7. CASiGEN Pharma Receives A World-wide Exclusive License From GIBH To Bring New Potential Diabetes Treatments To The Global Market
8. Pressure BioSciences, Inc. and Target Discovery, Inc. Expand Strategic License Agreement and Collaboration Supporting TDIs Planned Offering of Personalized Medicine Clinical Diagnostic Services
9. MetaStat, Inc. Executes Two New Licenses
10. Cara Therapeutics Licenses Novel Kappa Opioid Agonist, CR845, to Chong Kun Dang Pharmaceutical Corporation For South Korean Market
11. Ventana licenses Gen-Probe IP for measuring ERG protein in prostate cancer patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/31/2015)... CORAL SPRINGS, Fla. , March 31, 2015 ... technology (HIT) strategy and management consulting firm, has ... reference publication to enable health IT vendors, payers ... environment for the electronic prior authorization (ePA) of ... prescription prior authorization (PA) requests are completed through ...
(Date:3/31/2015)... Mar. 27, 2015 Research and Markets ... "Intraoperative Imaging Market by Type (Intraoperative CT, Intraoperative ... report to their offering. The global intraoperative ... of 3.5% from 2014 to 2019 It ... a number of forces that favor this market. The ...
(Date:3/31/2015)... 31, 2015 Accelerated orthodontic treatment will ... of Orthodontics 2015 Annual Session, May 15-19, as ... lectures on AcceleDent ® . Manufactured by OrthoAccel ... orthodontics, AcceleDent is a FDA-cleared, Class II medical ... much as 50 percent with just 20 minutes ...
Breaking Medicine Technology:Point-of-Care Partners Launches the ePA State Navigator 2Global Intraoperative Imaging (Intraoperative CT, Intraoperative MRI, Intraoperative Ultrasound) Market 2015-2019 2Leading Orthodontists to Advance Accelerated Treatment at AAO 2015 2Leading Orthodontists to Advance Accelerated Treatment at AAO 2015 3
... Medical ® today announced that it received Australian Therapeutic ... System for endoscopic lung volume reduction for the treatment ... lung volume reduction system for the treatment of severe ... leaving implants or foreign materials in the lung. ...
... Nev., Dec. 21, 2011   Denali Concrete Management Inc. ... patient enrollment for a phase 3 clinical study of ... in patients with moderate-to-severe Dry Eye Syndrome. This multi-center ... and Israel. The randomized, double-masked clinical trial will include ...
Cached Medicine Technology:Uptake Medical Announces TGA Approval of InterVapor for Patients With Severe Emphysema 2Uptake Medical Announces TGA Approval of InterVapor for Patients With Severe Emphysema 3Denali Concrete Management Inc. Announces the Commencement of Patient Enrollment for the Phase 3 Dry Eye Syndrome Study 2
(Date:3/31/2015)... (PRWEB) March 31, 2015 At Summit Breast ... all patients in a calm and caring manner. , Summit ... diagnosis and surgical treatment of breast cancer. They treat ... but from all over the world. Their doctors continue ... publications. , The seeds for Summit Breast Care were planted ...
(Date:3/31/2015)... March 31, 2015 Dr. Uzma Parvez is ... 19th, Dr. Parvez conducted Grand Grounds Presentations at St. Michael’s ... and Managing Side Effects”. The event was attended by ... She received very positive feedback from the Grand Rounds. ... that they’ve had in a while. , Ahead, Dr. ...
(Date:3/31/2015)... Beckman Coulter is sponsoring a new ... Particulate Matter in Therapeutic Protein Injections”,” an educational session that ... counting particles in liquids, with a focus on the challenges ... to attend and will be broadcast live April 8, 2015 ... test for protein-based materials, known as USP 787 , ...
(Date:3/31/2015)... (PRWEB) March 31, 2015 Former 49ers linebacker ... than during his first year of a promising NFL career. ... Sports on Earth Senior Writer Will Leitch explores the ... league. Leitch talks about the decision making process that Borland ... preservation of health over a large paycheck, and what impact, ...
(Date:3/31/2015)... 2015 BESLER Consulting today announced ... Value of an Independent Cost Report Review.” , ... critical role in the determination of Medicare reimbursement ... understanding and review, this report can assist management ... , This white paper discusses:, ...
Breaking Medicine News(10 mins):Health News:Summit Breast Care is Celebrating Four Years as "NJ Top Docs" 2Health News:NJ Top Docs Presents, Dr. Uzma Parvez of Total Pain Care 2Health News:Beckman Coulter Webinar Series Presents Insight into New Demands in Counting Particles in Liquids 2Health News:Beckman Coulter Webinar Series Presents Insight into New Demands in Counting Particles in Liquids 3Health News:Will Leitch and the Curious Case of Chris Borland on SCI TV 2Health News:Will Leitch and the Curious Case of Chris Borland on SCI TV 3
... UK (September 1, 2010) Faith based schools are ... standards. But are religious values at odds with legislation ... Education Management Administration and Leadership published by SAGE shows ... state diverge, with unfortunate consequences for gay students and ...
... By Steven Reinberg HealthDay Reporter , TUESDAY, ... fruits and vegetables and low in saturated fats can ... mildly elevated blood pressure, Johns Hopkins University researchers say. ... (Dietary Approaches to Stop Hypertension) -- was designed to lower ...
... is the leading cause of cancer deaths worldwide, and ... successful. Furthermore, the incidence of one type of lung ... better understanding of the changes in tumor cell biology ... of an abnormal mass of tissue) that have been ...
... fewer than eight hours of sleep per night have greater ... depressive and anxious symptoms, according to a study in the ... Using an average self-reported nightly sleep duration of eight to ... association between sleep durations of less than eight hours and ...
... expedite the communication of urgent findings and improve patient ... of the Journal of the American College of ... in the United States is moving toward 24/7 coverage, ... as computed tomography (CT) and magnetic resonance imaging (MRI) ...
... A new study underscores the importance for women with a family ... testing for the BRCA1 and BRCA2 genes that make them more ... Medicine oncologist. The study, which will be published in ... Association ( JAMA ), shows women with the gene live longer ...
Cached Medicine News:Health News:Keeping faith -- schools must balance ethos with equality 2Health News:'DASH Diet' Shown to Lower Heart Attack Risk Almost 20% 2Health News:'DASH Diet' Shown to Lower Heart Attack Risk Almost 20% 3Health News:Tumor budding identified as predictor for unfavorable outcome in lung cancer 2Health News:Study links shorter sleep durations with greater risks of mental distress in young adults 2Health News:Study links shorter sleep durations with greater risks of mental distress in young adults 3Health News:Staggered radiologist work shifts improve patient care, study suggests 2Health News:Preventive cancer surgeries save women's lives 2
The full access underbody blanket is positioned on the procedure table before the patient arrives to the room....
The cath lab blanket, designed for use in the Cardiac Cath Lab, surrounds the patient with warm air and allows unrestricted access to the femoral artery....
The Bair Hugger outpatient blanket makes it easy to give your patients the benefit of prewarming and enhance patient comfort during outpatient procedures....
The ThermoWrap™ enables true normothermia (36.5°C - 37.5°C), induced hypothermia and precise rewarming....
Medicine Products: